1.Gao J, Wu F, Wu S, Yang X. Inflammatory Subtypes in Classic Asthma and Cough Variant Asthma. J Inflamm Res. 2020;13:1167-73.
2.Morice AH, Millqvist E, Bieksiene K, Birring SS, Dicpinigaitis P, Domingo Ribas C, et al. ERS guidelines on the diagnosis and treatment of chronic cough in adults and children. Eur Respir J. 2020;55(1):1901136.
3.Côté A, Russell RJ, Boulet LP, Gibson PG, Lai K, Irwin RS, et al. Managing Chronic Cough Due to Asthma and NAEB in Adults and Adolescents: CHEST Guideline and Expert Panel Report. Chest. 2020;158(1):68-96.
4.Ibrahim Arif S, Amer YS, Adnan Alkamal T, Abdulrahman Binsaeed M, Ibrahim Arif B, Dhaifallah Albaqami M, et al. Patient response to the management during the acute presentation of cough variant Asthma: Retrospective cohort study. Saudi J Biol Sci. 2023;30(12):103875.
5.Yi F, Zhan C, Liu B, Li H, Zhou J, Tang J, et al. Effects of treatment with montelukast alone, budesonide/formoterol alone and a combination of both in cough variant asthma. Respir Res. 2022;23(1):279.
6.Zhou J, Yi F, Wu F, Xu P, Chen M, Shen H, et al. Characteristics of different asthma phenotypes associated with cough: a prospective, multicenter survey in China. Respir Res. 2022;23(1):243.
7.Ramos-Ramírez P, Tliba O. Glucocorticoid Insensitivity in Asthma: The Unique Role for Airway Smooth Muscle Cells. Int J Mol Sci. 2022;23(16):8966.
8.Matsumura Y. Inadequate therapeutic responses to glucocorticoid treatment in bronchial asthma. J Int Med Res. 2023;51(6):3000605231175746.
9.Asthma Workgroup, Chinese Society, Respiratory, Diseases (CSRD), Chinese Medical, Association. The Chinese national guidelines on diagnosis and management of cough (December 2010). Chin Med J (Engl). 2011;124(20):3207-19.
10.Lai K, Zhan W, Wu F, Zhang Y, Lin L, Li W, et al. Clinical and Inflammatory Characteristics of the Chinese APAC Cough Variant Asthma Cohort. Front Med (Lausanne). 2022;8(14):807385.
11.Niu Y, Cao M, Li S, Mo J, Zhu Z, Wang H. The Effects of Budesonide Inhalation Treatment on the Expression Levels of Serum IL-6, TGF- β1, and IgE and Pulmonary Function in Patients with Cough Variant Asthma and an Evaluation of Treatment Efficacy. Int J Gen Med. 2024; 29(17):1253-61.
12.Wang XP, Yang LD, Zhou JF. Montelukast and budesonide combination for children with chronic cough-variant asthma. Medicine (Baltimore). 2018;97(30):e11557.
13.Guo S, Cao C. Effects of montelukast sodium combined with budesonide on pulmonary function, serum IgE levels, and EOS percentage in children with comorbid allergic rhinitis and asthma. Am J Transl Res. 2023;15(12):6823-31.
14.Song Y, Li R. Effect of budesonide combined with salbutamol nebulization on pulmonary function and serum immune factors in children with bronchiolitis. Am J Transl Res. 2021;15;13(7):8158 -64.
15.Pace E, Di Sano C, Ferraro M, Bruno A, Caputo V, Gallina S, et al. Budesonide increases TLR4 and TLR2 expression in Treg lymphocytes of allergic asthmatics.Pulm Pharmacol Ther. 2015;32(8):93-100.
16.Dai L, Liu B, Lin J, Jiang Y, Li Y, Yao Z, et al. Long-acting anti-inflammatory injectable DEX-Gel with sustained release and self-healing properties regulates TH1/TH2 immune balance for minimally invasive treatment of allergic rhinitis. J Nanobiotechnolog y. 2024;22(1):51.
17.Pace E, Di Sano C, La Grutta S, Ferraro M, Albeggiani G, Liotta G, et al. Multiple in vitro and in vivo regulatory effects of budesonide in CD4+ T lymphocyte subpopulations of allergic asthmatics. PLoS One. 2012;7(12):e48816.
18.Tang Q, Lei H, You J, Wang J, Cao J. Evaluation of efficiency and safety of combined montelukast sodium and budesonide in children with cough variant asthma: A protocol for systematic review and meta-analysis. Medicine (Baltimore). 2021;100(25):e26416.
19.Jin FD, Wang J, Deng SJ, Song WJ, Zhang X, Wang CY, et al. Interaction effect of chronic cough and ageing on increased risk of exacerbation in patients with asthma: a prospective cohort study in a real-world setting. ERJ Open Res. 2023 Dec 27;9(6):00461-2023.
20.McGeachie MJ, Sordillo JE, Dahlin A, Wang AL, Lutz SM, Tantisira KG, et al. Expression of SMARCD1 interacts with age in association with asthma control on inhaled corticosteroid therapy.Respir Res. 2020;21(1):31.
21.Ganji V, Al-Obahi A, Yusuf S, Dookhy Z, Shi Z. Serum vitamin D is associated with improved lung function markers but not with prevalence of asthma, emphysema, and chronic bronchitis. Sci Rep. 2020;10(1):11542
22.Uzer F, Ozbudak O. Are 25(OH) D concentrations associated with asthma control and pulmonary function test? Caspian J Intern Med. 2019;10(4):377-382.
23.Jaura J, Kelsberg G, Safranek S. Does vitamin D supplementation reduce asthma exacerbations? J Fam Pract. 2020;69(4):E4-E6.
24.Jolliffe DA, Stefanidis C, Wang Z, Kermani NZ, Dimitrov V, White JH, et al. Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 2020;202(3):371 -82.
25.Chen L, Huang M, Xie N. The effect of montelukast sodium plus budesonide on the clinical efficacy, inflammation, and pulmonary function in children with cough variant asthma. Am J Transl Res. 2021;13(6):6807-16.
26.Ricciardolo FLM, Folkerts G, Folino A, Mognetti B.Bradykinin in asthma: Modulation of airway inflammation and remodelling. Eur J Pharmacol. 2018;827(16):181-8.